New prototype project titled advanced wound care solutions for multidrug resistant infections and hemorrhage control in battlefield conditions (proposal number mtec-25-04-multitopic-005)
Active Awarded Last action
- Contract number
- HT94252590022
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,820,213
Award facts
- Contract value 100% obligated
- $4,820,212.78 Current and potential, with all options
- Completion date 35% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Memsel Inc.
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded an Other Transaction Order valued at $4.82M to Medical Technology Enterprise Consortium (MTEC) on August 22, 2025, for the development of advanced wound care solutions addressing multidrug-resistant infections and hemorrhage control in battlefield conditions. This prototype project, designated MTEC-25-04-MULTITOPIC-005, will be performed in Summerville, South Carolina, with a completion target of December 26, 2028. The award carries no set-aside designation and represents MTEC's continued engagement in the military medical technology development domain through its established Other Transaction Indefinite Delivery Vehicle with the Defense Health Agency.
MTEC, a nonprofit medical technology accelerator for the Department of Defense, leverages its consortium network of industry partners, academic institutions, and research organizations to rapidly prototype and field innovative medical solutions for military healthcare needs. This contract aligns with MTEC's core mission of translating medical research into practical applications for military personnel, building on its extensive portfolio of defense-related medical technology projects spanning traumatic brain injury solutions, regenerative medicine, infectious disease diagnostics, and operational medicine capabilities. The project focuses on critical battlefield medical challenges, reflecting the Defense Health Agency's commitment to advancing medical modernization and operational readiness for military forces.
Quick answers
Who was awarded contract HT94252590022?
HT94252590022 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on August 22, 2025.
How much is contract HT94252590022 worth?
The government has obligated $4,820,213 on HT94252590022.
Is contract HT94252590022 an order under another contract?
Yes. HT94252590022 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract HT94252590022 competed?
The extent of competition for HT94252590022 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award